What is the appropriate tapering regimen for a patient on Wellbutrin (bupropion) 150 mg daily for one month who is switching to sertraline?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Direct Cross-Taper Without Tapering Bupropion

For a patient on Wellbutrin (bupropion) 150 mg daily for only one month switching to sertraline, you can stop bupropion abruptly and start sertraline immediately without any taper. The short duration of bupropion treatment (1 month) makes withdrawal symptoms highly unlikely, and the low dose (150 mg) further reduces any risk 1.

Rationale for No Taper

The evidence strongly supports this approach:

  • Guideline recommendations state that discontinuing an antidepressant over 10-14 days limits withdrawal symptoms 1, but this applies primarily to longer-term use
  • FDA labeling for bupropion indicates tapering is recommended when discontinuing 300 mg daily doses (reducing to 150 mg before stopping), but makes no such requirement for patients already on 150 mg 2
  • Bupropion's mechanism (dopamine/norepinephrine reuptake inhibitor) differs from SSRIs, and withdrawal syndromes are less commonly reported compared to SSRIs like paroxetine, fluvoxamine, or sertraline 3
  • One month duration is insufficient to establish significant neuroadaptation requiring gradual discontinuation

Switching Protocol

Stop Bupropion

  • Discontinue 150 mg immediately (no taper needed)
  • No washout period required between medications

Start Sertraline

  • Begin sertraline 25-50 mg daily on the same day you stop bupropion 1
  • Take in morning or evening (patient preference)
  • After 1 week, increase to 50 mg daily if started at 25 mg
  • Target therapeutic dose: 50-200 mg daily based on response

Monitoring Considerations

Watch for these issues during the switch:

Potential bupropion discontinuation effects (unlikely at 1 month):

  • Mood changes
  • Irritability
  • Fatigue
  • These would be mild and transient if they occur at all

Sertraline initiation side effects 3:

  • Nausea (most common)
  • Diarrhea
  • Insomnia or somnolence
  • Headache
  • Sexual dysfunction (may develop over weeks)

Important safety note: There is no contraindication to combining bupropion and sertraline briefly, and no significant drug-drug interaction between them 4. However, since you're stopping bupropion immediately, this is not relevant.

Key Pitfalls to Avoid

  • Do not use alternate-day dosing as a tapering strategy—recent evidence shows this causes severe receptor occupancy fluctuations and increases withdrawal risk 5
  • Do not delay starting sertraline waiting for bupropion to "clear"—there's no pharmacological reason for a washout period between these two medications
  • Do not confuse this with MAOI switches, which require 14-day washouts 2, 6

When Tapering Would Be Indicated

Bupropion tapering becomes important when:

  • Patient has been on 300 mg daily (reduce to 150 mg before stopping) 2
  • Duration of treatment exceeds several months
  • Patient has history of withdrawal symptoms from other medications
  • Patient requests gradual discontinuation due to anxiety about stopping

In your specific case—150 mg for 1 month—proceed with immediate discontinuation and same-day sertraline initiation.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.